MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,630,262 | -20.0% | 24,858 | +26.6% | 0.00% | -25.0% |
Q2 2023 | $4,536,147 | +44.7% | 19,637 | +51.8% | 0.00% | +33.3% |
Q1 2023 | $3,134,360 | +49.7% | 12,938 | -27.7% | 0.00% | +50.0% |
Q1 2021 | $2,094,000 | +5.2% | 17,900 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,990,000 | -8.4% | 17,900 | -2.2% | 0.00% | 0.0% |
Q3 2020 | $2,173,000 | +8.4% | 18,300 | +3.4% | 0.00% | 0.0% |
Q2 2020 | $2,005,000 | +84.3% | 17,700 | +8.6% | 0.00% | +100.0% |
Q1 2020 | $1,088,000 | -27.6% | 16,300 | -1.2% | 0.00% | 0.0% |
Q4 2019 | $1,503,000 | +24.5% | 16,500 | +17.9% | 0.00% | 0.0% |
Q3 2019 | $1,207,000 | +84.6% | 14,000 | +124.4% | 0.00% | 0.0% |
Q2 2019 | $654,000 | -4.0% | 6,238 | +14.7% | 0.00% | 0.0% |
Q1 2019 | $681,000 | +9.1% | 5,438 | -1.8% | 0.00% | 0.0% |
Q4 2018 | $624,000 | -72.8% | 5,538 | -48.3% | 0.00% | -66.7% |
Q3 2018 | $2,295,000 | +38.9% | 10,718 | +81.4% | 0.00% | +50.0% |
Q2 2018 | $1,652,000 | +265.5% | 5,908 | +52.7% | 0.00% | +100.0% |
Q1 2018 | $452,000 | – | 3,868 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |